Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: Cost effectiveness evaluation

BMJ (Online)

Volumn 343, Issue 7827, 2011, Pages

  Robotham, Julie V ^a   Graves, Nicholas ^b   Cookson, Barry D ^a   Barnett, Adrian G ^b   Wilson, Jennie A ^c   Edgeworth, Jonathan D ^d,e   Batra, Rahul ^e   Cuthbertson, Brian H ^f   Cooper, Ben S ^g,h  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g MAHIDOL UNIVERSITY   (Thailand)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL DECOLONIZATION; BACTERIUM ISOLATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEATH; DYNAMIC TRANSMISSION MODEL; HEALTH CARE COST; HIGH RISK PATIENT; INFECTION CONTROL; INTENSIVE CARE UNIT; MEDICAL FEE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MODEL; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCREENING TEST; UNITED KINGDOM; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION;

COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MASS SCREENING; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 84859001819     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d5694     Document Type: Article

References (65)

1. Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365:295-304. (Pubitemid 40139106)
2. Jeyaratnam D, Whitty CJM, Phillips K, Liu D, Orezzi C, Ajoku U, et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008;336:927-30. (Pubitemid 351632018)
3. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010;362:9-17.
4. Hardy K, Price C, Szczepura A, Gossain S, Davies R, Stallard N, et al. Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 2010;16:333-9.
5. Porter R, Subramani K, Thomas AN, Chadwick P. Nasal carriage of Staphylococcus aureus on admission to intensive care: incidence and prognostic significance. Intensive Care Med 2003;29:655-8. (Pubitemid 36523685)
6. Samad A, Banerjee D, Carbarns N, Ghosh S. Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. J Hosp Infect 2002;51:43-6. (Pubitemid 37554841)
7. Theaker C, Ormond-Walshe S, Azadian B, Soni N. MRSA in the critically ill. J Hosp Infect 2001;48:98-102. (Pubitemid 32700708)
8. Thompson DS. Methicillin-resistant Staphylococcus aureus in a general intensive care unit. J R Soc Med 2004;97:521-6. (Pubitemid 39524202)
9. Dancer SJ, Coyne M, Speekenbrink A, Samavedam S, Kennedy J, Wallace PGM. MRSA acquisition in an intensive care unit. Am J Infect Control 2006;34:10-7. (Pubitemid 43144350)
10. Harbarth S, Sax H, Fankhauser-Rodriguez C, Schrenzel J, Agostinho A, Pittet D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006;119:15-23.
11. Eveillard M, Mortier E, Lancien E, Lescure F, Schmit J, Barnaud G, et al. Consideration of age at admission for selective screening to identify methicillin-resistant Staphylococcus aureus carriers to control dissemination in a medical ward. Am J Infect Control 2006;34:108-13.
12. Safdar N, Narans L, Gordon B, Maki DG. Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol 2003;41:3163-6. (Pubitemid 36842316)
13. Ben Nsira S, Dupuis M, Leclercq R. Evaluation of MRSA Select, a new chromogenic medium for the detection of nasal carriage of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2006;27:561-4. (Pubitemid 43767073)
14. Apfalter P, Assadian O, Kalczyk A, Lindenmann V, Makristathis A, Mustafa S, et al. Performance of a new chromogenic oxacillin resistance screen medium (Oxoid) in the detection and presumptive identification of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2002;44:209-11. (Pubitemid 35375818)
15. Lagacé-Wiens PR, Alfa MJ, Manickam K, Harding GK. Reductions in workload and reporting time by use of methicillin-resistant Staphylococcus aureus screening with MRSASelect medium compared to mannitol-salt medium supplemented with oxacillin. J Clin Microbiol 2008;46:1174-7. (Pubitemid 351563553)
16. Cunningham R, Jenks P, Northwood J, Wallis M, Ferguson S, Hunt S. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007;65:24-8. (Pubitemid 44932976)
17. Harbarth S, Masuet-Aumatell C, Schrenzel J, Francois P, Akakpo C, Renzi G, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 2006;10:R25.
18. Nahimana I, Francioli P, Blanc DS. Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006;12:1168-74. (Pubitemid 44762518)
19. Van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J. Methicillin-resistant Staphylococcus aureus (MRSA) detection: comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 2007;45:2486-90. (Pubitemid 47295478)
20. Perry JD, Davies A, Butterworth LA, Hopley ALJ, Nicholson A, Gould FK. Development and evaluation of a chromogenic agar medium for methicillin- resistant Staphylococcus aureus. J Clin Microbiol 2004;42:4519-23. (Pubitemid 39362365)
21. Compernolle V, Verschraegen G, Claeys G. Combined use of Pastorex Staph-Plus and either of two new chromogenic agars, MRSA ID and CHROMagar MRSA, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:154-8. (Pubitemid 46106422)
22. Van Hal SJ, Jennings Z, Stark D, Marriott D, Harkness J. MRSA detection: comparison of two molecular methods (BD GeneOhm PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs. Eur J Clin Microbiol Infect Dis 2009;28:47-53.
23. Zhang SX, Drews SJ, Tomassi J, Katz KC. Comparison of two versions of the IDI-MRSA assay using charcoal swabs for prospective nasal and nonnasal surveillance samples. J Clin Microbiol 2007;45:2278-80. (Pubitemid 47203807)
24. Keshtgar MRS, Khalili A, Coen PG, Carder C, Macrae B, Jeanes A, et al. Impact of rapid molecular screening for meticillin-resistant Staphylococcus aureus in surgical wards. Br J Surg 2008;95:381-6.
25. Huletsky A, Lebel P, Picard FJ, Bernier M, Gagnon M, Boucher N, et al. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis 2005;40:976-81. (Pubitemid 40418304)
26. Rossney AS, Herra CM, Fitzgibbon MM, Morgan PM, Lawrence MJ, O'Connell B. Evaluation of the IDI-MRSA assay on the SmartCycler real-time PCR platform for rapid detection of MRSA from screening specimens. Eur J Clin Microbiol Infect Dis 2007;26:459-66. (Pubitemid 47025030)
27. Warren DK, Guth RM, Coopersmith CM, Merz LR, Zack JE, Fraser VJ. Impact of a methicillin-resistant Staphylococcus aureus active surveillance program on contact precaution utilization in a surgical intensive care unit. Crit Care Med 2007;35:430-4. (Pubitemid 46148532)
28. Paule SM, Hacek DM, Kufner B, Truchon K, Thomson RBJ, Kaul KL, et al. Performance of the BD GeneOhm methicillin-resistant Staphylococcus aureus test before and during high-volume clinical use. J Clin Microbiol 2007;45:2993-8. (Pubitemid 47417345)
29. Bishop EJ, Grabsch EA, Ballard SA, Mayall B, Xie S, Martin R, et al. Concurrent analysis of nose and groin swab specimens by the IDI-MRSA PCR assay is comparable to analysis by individual-specimen PCR and routine culture assays for detection of colonization by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006;44:2904-8. (Pubitemid 44228588)
30. Kypraios T, O'Neill PD, Huang SS, Rifas-Shiman SL, Cooper BS. Assessing the role of undetected colonization and isolation precautions in reducing methicillin-resistant Staphylococcus aureus transmission in intensive care units. BMC Infect Dis 2010;10:29.
31. Rohr U, Mueller C, Wilhelm M, Muhr G, Gatermann S. Methicillin-resistant Staphylococcus aureus wholebody decolonisation among hospitalized patients with variable site colonisation by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 2003;54:305-9. (Pubitemid 37554927)
32. Van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008;8:CD006216.
33. O'Hagan A, Buck C, Daneshkhah A, Eiser JR, Garthwaite PH, Jenkinson D, et al. Uncertain judgements: eliciting experts' probabilities. Wiley, 2006.
34. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74. (Pubitemid 40445022)
35. Graves N, Halton K, Lairson D. Economics and preventing hospital-acquired infection - broadening the perspective. Infect Control Hosp Epidemiol 2007;28:178-84. (Pubitemid 46374158)
36. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561-6. (Pubitemid 38420284)
37. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care 2010;14:R6.
38. Barnett AG, Batra R, Graves N, Edgeworth J, Robotham J, Cooper B. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit. Am J Epidemiol 2009;170:1186-94.
39. Graves N, Halton K, Curtis M, Doidge S, Lairson D, McLaws M, et al. Costs of surgical site infection that appear after discharge. Emerg Infect Dis 2006;12:831-5.
40. Graves N, Halton K, Doidge S, Clements A, Lairson D, Whitby M. Who bears the cost of healthcare-acquired surgical site infection? J Hosp Infect 2008;69:274-82.
41. Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. BMJ 2004;329:224-7. (Pubitemid 39013284)
42. Claxton K, Sculpher M, McCabe C, Briggs A, Akehurst R, Buxton M, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005;14:339-47. (Pubitemid 40514748)
43. Barton G, Briggs A, Fenwick E. Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfect information (EVPI). Value Health 2008;11:886-97.
44. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50:210-7.
45. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41:11-8. (Pubitemid 28064245)
46. Girou E, Chai SH, Oppein F, Legrand P, Ducellier D, Cizeau F, et al. Misuse of gloves: the foundation for poor compliance with hand-hygiene and potential for microbial transmission? J Hosp Infect 2004;57:162-9. (Pubitemid 38745430)
47. Roberts T, Robinson S, Barton P, Bryan S, McCarthy A, Macleod J, et al. The correct approach to modelling and evaluating chlamydia screening. Sex Transm Infect 2004;80:324-5. (Pubitemid 39070798)
48. De Vries R, Kretzschmar M, Schellekens JF, Versteegh FG, Westra TA, Roord JJ, et al. Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One 2010;5:e13392.
49. Turner K, Adams E, Grant A, Macleod J, Bell G, Clarke J, et al. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study. BMJ 2011;342:c7250.
50. Lee BY, Wiringa AE, Bailey RR, Goyal V, Tsui B, Lewis GJ, et al. The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2010;31:1130-8.
51. Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect 2010;16:1740-6.
52. Brown J, Paladino JA. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics 2010;28:567-75.
53. Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008;61:1216-21.
54. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073-9. (Pubitemid 350036706)
55. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010;145:240-6.
56. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30:959-63.
57. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37:1858-65.
58. Lee AS, Macedo-Vinas M, Francois P, Renzi G, Schrenzel J, Vernaz N, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011;52:1422-30.
59. Meyer B, Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control? J Hosp Infect 2010;76:200-5.
60. Ritchie K, Bradbury I, Eastgate J, Foster L, Iqbal K, MacPherson K, et al. Consultation report on health technology: clinical and cost effectiveness of screening for MRSA. NHS Quality Improvement Scotland, 2006.
61. Health Protection Scotland. Pathfinder implementation study. 2011. www.hps.scot.nhs. uk/haiic/sshaip/mrsascreeningprogramme.aspx.
62. Coia JE, Duckworth GJ, Edwards DI, Farrington M, Fry C, Humphreys H, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006;63:S1-44.
63. National Health Service. Clean, safe care: reducing MRSA and other healthcare associated infections. Department of Health. 2011. www.clean-safe-care.nhs.uk.
64. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcusaureus (MRSA): systematic review of the literature. BMJ 2004;329:533.
65. Jain R, Kralovic SM, Evans ME, Ambrose M, Simbartl LA, Obrosky DS, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 2011;364:1419-30.